Predictive Factors for Adverse Event Outcomes After Transarterial Radioembolization with Yttrium-90 Resin Microspheres in Europe: Results from the Prospective Observational CIRT Study

[1] Benson AB(2021)Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology J Natl Compr Canc Netw. 19 541-565

[2] D'Angelica MI(2021)Colon cancer, version 22021, NCCN clinical practice guidelines in oncology J Natl Compr Canc Netw. 19 329-359

[3] Abbott DE(2018)Electronic address EEE, European Association for the Study of the L. EASL clinical practice guidelines: management of hepatocellular carcinoma J Hepatol. 69 182-236

[4] Anaya DA(2011)EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds Eur J Nucl Med Mol Imaging 38 1393-1406

[5] Anders R(2016)Biliary cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 27 v28-v37

[6] Are C(2016)ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Ann Oncol 27 1386-1422

[7] Benson AB(2019)Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 30 871-873

[8] Venook AP(2018)Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the study of liver diseases Hepatology 68 723-750

[9] Al-Hawary MM(2021)Short-term Safety and quality of life outcomes following radioembolization in primary and secondary liver tumours: a multi-centre analysis of 200 patients in France Cardiovasc Intervent Radiol 44 36-49

[10] Arain MA(2017)Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials PLoS ONE 12 e0184597-376

[1] Benson AB(2021)Hepatobiliary cancers, version 2.2021, NCCN clinical practice guidelines in oncology J Natl Compr Canc Netw. 19 541-565

[2] D'Angelica MI(2021)Colon cancer, version 22021, NCCN clinical practice guidelines in oncology J Natl Compr Canc Netw. 19 329-359

[3] Abbott DE(2018)Electronic address EEE, European Association for the Study of the L. EASL clinical practice guidelines: management of hepatocellular carcinoma J Hepatol. 69 182-236

[4] Anaya DA(2011)EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds Eur J Nucl Med Mol Imaging 38 1393-1406

[5] Anders R(2016)Biliary cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 27 v28-v37

[6] Are C(2016)ESMO consensus guidelines for the management of patients with metastatic colorectal cancer Ann Oncol 27 1386-1422

[7] Benson AB(2019)Hepatocellular carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 30 871-873

[8] Venook AP(2018)Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the study of liver diseases Hepatology 68 723-750

[9] Al-Hawary MM(2021)Short-term Safety and quality of life outcomes following radioembolization in primary and secondary liver tumours: a multi-centre analysis of 200 patients in France Cardiovasc Intervent Radiol 44 36-49

[10] Arain MA(2017)Comparative effectiveness of different transarterial embolization therapies alone or in combination with local ablative or adjuvant systemic treatments for unresectable hepatocellular carcinoma: A network meta-analysis of randomized controlled trials PLoS ONE 12 e0184597-376